ClinConnect ClinConnect Logo
Search / Trial NCT06483113

DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study

Launched by ALCON RESEARCH · Jun 26, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Contact Lenses

ClinConnect Summary

This study includes a Baseline visit and a Year 1 visit.

The Baseline visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a DAILIES TOTAL1 sphere, toric, or multifocal soft contact lens prescription was released. The Baseline visit will be retrospective. All assessments at baseline will be obtained from chart reviews.

The Year 1 visit is defined as the visit that occurs 1 year (-2/+4 months) since the Baseline visit during which period the subject is wearing prescribed lenses and a ...

Gender

ALL

Eligibility criteria

  • Key Inclusion Criteria:
  • At baseline: 7 years of age or older for sphere and toric wearers, 40 years of age or older for multifocal wearers.
  • Wearers of delefilcon A (sphere, toric, or multifocal) soft contact lenses of the same design in both eyes who have already begun use of the lens type and have purchased at least 3-month supply of lenses at baseline.
  • Best corrected distance visual acuity (BCVA) 20/25 or better in each eye at baseline.
  • Other protocol-defined inclusion criteria may apply.
  • Key Exclusion Criteria:
  • Any ocular disease or condition that would contraindicate contact lens wear at baseline.
  • Use of systemic or ocular medications that would contraindicate contact lens wear at baseline.
  • Other protocol-defined exclusion criteria may apply.

About Alcon Research

Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.

Locations

Spokane, Washington, United States

Medina, Minnesota, United States

Memphis, Tennessee, United States

Edina, Minnesota, United States

Saint Louis, Missouri, United States

Eden Prairie, Minnesota, United States

San Diego, California, United States

West Palm Beach, Florida, United States

Fort Worth, Texas, United States

San Diego, California, United States

Ponte Vedra Beach, Florida, United States

New York, New York, United States

Saint George, Utah, United States

Patients applied

0 patients applied

Trial Officials

Clinical Trial Lead, Vision Care

Study Director

Alcon Research, LLC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported